Alcoholic Neuropathy, DEPRESSIVE DISORDER, HEART DISEASE, Liver Failure
Conditions
Keywords
heart failure, liver, depression, neuropathy
Brief summary
Alcohol abuse is associated with a variety of clinical diseases, but studies on prevalence of different somatic diseases among alcohol abusers are lacking. Studies on populations in an out-day patients' clinic are also lacking. The investigators aim to study somatic health standard in an out-day patients' clinic population of alcohol abusers, with regard to prevalence of different kinds of somatic diseases, and how the interaction of somatic and psychiatric treatment can influence on patients quality of life. Clinical examination including blood samples and echocardiographic examinations in all participants, other additional examinations (as x-ray, CT or MRI if indicated by clinical findings).
Detailed description
Retrospective methods will be used to study former somatic disease, cross-section design to study present somatic disease and prospective design to study quality of life, psychiatric and somatic health after combination of psychiatric and somatic examinations and treatment.
Interventions
OTHERPsychiatric and somatic examinations and ,if clinical indicated, treatment
Patients referred to the clinic will be given optimal treatment for revealed psychiatric and/or somatic disease including conversational therapy, and if indicated therapeutic interventions with respect to any kind of disease.
Sponsors
Helse Nord-Trøndelag HF
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Alcohol abusers reffered to the out-day patients' clinic at Dep. of Psychiatry, Levanger Hospital, Norway
Exclusion criteria
* Not consenting to participate * Not able to consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of different kinds of somatic disease | 3 months after inclusion | Prevalence of somatic disease at study attendance of any kind, specified for heart disease, gall- and liver disease, neuropathic disease. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Prevalence of former somatic disease | 3 months after inclusion | Prevalence of former somatic disease investigated by anamnestic examination, search in patient journals and communication with the patients community health service. |
| Outcome of psychiatric and somatic treatment of alcohol abusers | 1 year after stopped inclusion | Quality of life and score of somatic and psychiatric health 1 year after inclusion |
Countries
Norway
Outcome results
None listed